Skip to main content

Advertisement

Log in

Association between intracellular infectious agents and Tourette’s syndrome

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

The underlying pathophysiological mechanisms in Tourette’s syndrome (TS) are still unclear. Increasing evidence supports the involvement of infections, possibly on the basis of an altered immune status. Not only streptococci but also other infectious agents may be involved. This study investigates the association between the neurotrophic agents Chlamydia, Toxoplasma and TS. 32 patients with TS and 30 healthy matched controls were included. For each individual, IgA/IgG antibody titers against Chlamydia trachomatis/pneumoniae and Toxoplasma gondii were evaluated and analyzed with Fisher’s exact test. We found a significantly higher rate of TS patients with elevated antibody titers against Chlamydia trachomatis (P = 0.017) as compared to controls. A trend toward a higher prevalence in the Tourette’s group was shown for Toxoplasma (P = 0.069). In conclusion, within the TS patients a higher rate of antibody titers could be demonstrated, pointing to a possible role of Chlamydia and Toxoplasma in the pathogenesis of tic disorders. Because none of these agents has been linked with TS to date, a hypothesis is that infections could contribute to TS by triggering an immune response. It still remains unclear whether tic symptoms are partly due to the infection or to changes in the immune balance caused by an infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anonymous (2007) Psychiatric challenges throughout the life span. In: Abstracts of the Second Meeting of West European Societies of Biological Psychiatry. December 13–15, 2007. Strasbourg, France. Eur Arch Psychiatry Clin Neurosci 257(Suppl 2):4–61

  2. Behen M, Chugani HT, Juhasz C, Helder E, Ho A, Maqbool M, Rothermel RD, Perry J, Muzik O (2007) Abnormal brain tryptophan metabolism and clinical correlates in Tourette syndrome. Mov Disord 22(15):2256–2262

    Article  PubMed  Google Scholar 

  3. Bertozzi LC, Suzuki LA, Rossi CL (1999) Serological diagnosis of toxoplasmosis: usefulness of IgA detection and IgG avidity determination in a patient with a persistent IgM antibody response to Toxoplasma gondii. Rev Inst Med Trop Sao Paulo 41(3):175–177

    PubMed  Google Scholar 

  4. Bruun RD, Budman CL (1997) The course and prognosis of Tourette syndrome. Neurol Clin 15(2):291–298

    Article  CAS  PubMed  Google Scholar 

  5. Budman CL, Kerjakovic M, Bruun RD (1997) Viral infection and tic exacerbation. J Am Acad Child Adolesc Psychiatry 36(2):162

    Article  CAS  PubMed  Google Scholar 

  6. Burd L, Li Q, Kerbeshian J, Klug MG, Freeman RD (2009) Tourette syndrome and comorbid pervasive developmental disorders. J Child Neurol 24(2):170–175

    Article  PubMed  Google Scholar 

  7. Cevenini R, Sarov I, Rumpianesi F, Donati M, Melega C, Varotti C, La PM (1984) Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test. J Clin Pathol 37(6):686–691

    Article  CAS  PubMed  Google Scholar 

  8. Costantino G (2009) New promises for manipulation of kynurenine pathway in cancer and neurological diseases. Expert Opin Ther Targets 13(2):247–258

    Article  CAS  PubMed  Google Scholar 

  9. Cragnolini JJ, Garcia-Medel N, de Castro JA (2009) Endogenous processing and presentation of T-cell epitopes from Chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis. Mol Cell Proteomics 8(8):1850–1859

    Article  CAS  PubMed  Google Scholar 

  10. Ercan TE, Ercan G, Severge B, Arpaozu M, Karasu G (2008) Mycoplasma pneumoniae infection and obsessive-compulsive disease: a case report. J Child Neurol 23(3):338–340

    Article  PubMed  Google Scholar 

  11. Gavin L, MacKay AP, Brown K, Harrier S, Ventura SJ, Kann L, Rangel M, Berman S, Dittus P, Liddon N, Markowitz L, Sternberg M, Weinstock H, vid-Ferdon C, Ryan G (2009) Sexual and reproductive health of persons aged 10–24 years—United States, 2002–2007. MMWR Surveill Summ 58(6):1–58

    PubMed  Google Scholar 

  12. Grisham JR, Anderson TM, Sachdev PS (2008) Genetic and environmental influences on obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 258(2):107–116

    Article  PubMed  Google Scholar 

  13. Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP (1996) Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 320(Pt 2):595–597

    CAS  PubMed  Google Scholar 

  14. Hoekstra PJ, Anderson GM, Troost PW, Kallenberg CG, Minderaa RB (2007) Plasma kynurenine and related measures in tic disorder patients. Eur Child Adolesc Psychiatry 16(Suppl 1):71–77

    Article  PubMed  Google Scholar 

  15. Hoekstra PJ, Kallenberg CG, Korf J, Minderaa RB (2002) Is Tourette’s syndrome an autoimmune disease? Mol Psychiatry 7(5):437–445

    Article  CAS  PubMed  Google Scholar 

  16. Ikejima H, Friedman H, Yamamoto Y (2006) Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease. J Med Microbiol 55 (Pt 7): 947–952

    Google Scholar 

  17. Jankovic J (2001) Tourette’s syndrome. N Engl J Med 345(16):1184–1192

    Article  CAS  PubMed  Google Scholar 

  18. Kirvan CA, Swedo SE, Snider LA, Cunningham MW (2006) Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 179(1–2):173–179

    Article  CAS  PubMed  Google Scholar 

  19. Krause KH, Dresel S, Krause J, Kung HF, Tatsch K, Lochmuller H (2002) Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/hyperactivity disorder: positive effect of methylphenidate. J Neurol 249(8):1116–1118

    Article  PubMed  Google Scholar 

  20. Leckman JF, Cohen DJ, Goetz CG, Jankovic J (2001) Tourette syndrome: pieces of the puzzle. Adv Neurol 85:369–390

    CAS  PubMed  Google Scholar 

  21. Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kronig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, King RA (2005) Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette’s syndrome. Biol Psychiatry 57(6):667–673

    Article  CAS  PubMed  Google Scholar 

  22. Leckman JF, Peterson BS, Anderson GM, Arnsten AF, Pauls DL, Cohen DJ (1997) Pathogenesis of Tourette’s syndrome. J Child Psychol Psychiatry 38(1):119–142

    Article  CAS  PubMed  Google Scholar 

  23. Leweke FM, Gerth CW, Koethe D, Klosterkotter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH (2004) Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 254(1):4–8

    Article  PubMed  Google Scholar 

  24. Mell LK, Davis RL, Owens D (2005) Association between streptococcal infection and obsessive-compulsive disorder, Tourette’s syndrome, and tic disorder. Pediatrics 116(1):56–60

    Article  PubMed  Google Scholar 

  25. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR (2004) Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291(18):2229–2236

    Article  CAS  PubMed  Google Scholar 

  26. Morris CM, Pardo-Villamizar C, Gause CD, Singer HS (2009) Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci 276(1–2):45–48

    Article  CAS  PubMed  Google Scholar 

  27. Muller N, Riedel M, Blendinger C, Oberle K, Jacobs E, Abele-Horn M (2004) Mycoplasma pneumoniae infection and Tourette’s syndrome. Psychiatry Res 129(2):119–125

    Article  PubMed  Google Scholar 

  28. Muller N, Riedel M, Forderreuther S, Blendinger C, Abele-Horn M (2000) Tourette’s syndrome and Mycoplasma pneumoniae infection. Am J Psychiatry 157(3):481–482

    Article  CAS  PubMed  Google Scholar 

  29. Muller N, Riedel M, Hadjamu M, Schwarz MJ, Ackenheil M, Gruber R (1999) Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am J Psychiatry 156(4):634–636

    CAS  PubMed  Google Scholar 

  30. Muller N, Schwarz M (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10(2):131–148

    Article  CAS  PubMed  Google Scholar 

  31. Rickards H, Dursun SM, Farrar G, Betts T, Corbett JA, Handley SL (1996) Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette’s syndrome. Psychol Med 26(4):857–862

    Article  CAS  PubMed  Google Scholar 

  32. Riedel M, Straube A, Schwarz MJ, Wilske B, Muller N (1998) Lyme disease presenting as Tourette’s syndrome. Lancet 351(9100):418–419

    Article  CAS  PubMed  Google Scholar 

  33. Savolainen E, Kettunen A, Narvanen A, Kautiainen H, Karkkainen U, Luosujarvi R, Kaipiainen-Seppanen O (2009) Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000. Scand J Rheumatol 18:1–4

    Google Scholar 

  34. Shulman ST (2009) Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update. Curr Opin Pediatr 21(1):127–130

    Article  PubMed  Google Scholar 

  35. Silveira MF, Ghanem KG, Erbelding EJ, Burke AE, Johnson HL, Singh RH, Zenilman JM (2009) Chlamydia trachomatis infection during pregnancy and the risk of preterm birth: a case-control study. Int J STD AIDS 20(7):465–469

    Article  CAS  PubMed  Google Scholar 

  36. Snider LA, Swedo SE (2004) PANDAS: current status and directions for research. Mol Psychiatry 9(10):900–907

    Article  CAS  PubMed  Google Scholar 

  37. Steeves TD, Fox SH (2008) Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res 172:495–513

    Article  CAS  PubMed  Google Scholar 

  38. Tanner CM, Goldman SM (1997) Epidemiology of Tourette syndrome. Neurol Clin 15(2):395–402

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study has been financed by own resources of the Department of Psychiatry of the Ludwig-Maximilians University Munich, Germany and no research grants from other sources were involved.

Conflicts of interest statement

All authors report no biomedical financial interest or potential conflicts of interest for the research covered in the article submitted

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniela Krause.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krause, D., Matz, J., Weidinger, E. et al. Association between intracellular infectious agents and Tourette’s syndrome. Eur Arch Psychiatry Clin Neurosci 260, 359–363 (2010). https://doi.org/10.1007/s00406-009-0084-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-009-0084-3

Keywords

Navigation